1-4 of 4
John W. Sweetenham
Close
Sort by
Journal Articles

Following aggressive B-cell lymphoma

John W. Sweetenham
Journal: Blood
Blood (2015) 125 (24): 3673–3674.
https://doi.org/10.1182/blood-2015-04-641738
Published: 2015
Journal Articles

Risk Factors and Outcomes for Relapse after Autologous Stem Cell Transplantation for Hodgkin Lymphoma.

Robert M. Dean, MD, John W. Sweetenham, MD, Tao Jin, PhD, Stacey Brown, MS, Brad Pohlman, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Steve Andresen, MD, Edward A. Copelan, MD, Brian J. Bolwell, MD
Journal: Blood
Blood (2007) 110 (11): 1903.
https://doi.org/10.1182/blood.V110.11.1903.1903
Published: 2007
Journal Articles

When May Patients Be Considered Cured after Autografting for Hodgkin Lymphoma?.

Robert M. Dean, MD, John W. Sweetenham, MD, Tao Jin, PhD, Stacey Brown, MS, Brad Pohlman, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Steve Andresen, MD, Edward Copelan, MD, Brian J. Bolwell, MD
Journal: Blood
Blood (2007) 110 (11): 1909.
https://doi.org/10.1182/blood.V110.11.1909.1909
Published: 2007
Journal Articles

Analysis of V H Genes in Follicular and Diffuse Lymphoma Shows Ongoing Somatic Mutation and Multiple Isotype Transcripts in Early Disease With Changes During Disease Progression

Christian H. Ottensmeier, Andrew R. Thompsett, Delin Zhu, Bridget S. Wilkins, John W. Sweetenham, Freda K. Stevenson
Journal: Blood
Blood (1998) 91 (11): 4292–4299.
https://doi.org/10.1182/blood.V91.11.4292
Published: 1998